A Hospital-Based Population Screening for Peripheral Arterial Diseases in a North-East University Hospital of India

Author(s):  
Ajay K. Khanna ◽  
Divya Khanna ◽  
Himanshu Verma ◽  
T. B. Singh ◽  
Satyendra K. Tiwary ◽  
...  
2017 ◽  
Vol 119 (8) ◽  
pp. e63-e64
Author(s):  
Yusuf Can ◽  
Harun Kılıç ◽  
Murat Aksoy ◽  
İbrahim Kocayiğit ◽  
Mustafa Gökhan Vural ◽  
...  

ESC CardioMed ◽  
2018 ◽  
pp. 2739-2742
Author(s):  
Michal Tendera

Cardiac conditions other than CAD are frequent in patients with PADs. This is especially the case for heart failure and atrial fibrillation in patients with LEAD. In patients with symptomatic PADs, screening for heart failure should be considered. In patients with heart failure, screening for LEAD may be considered. Full vascular assessment is indicated in patients planned for heart transplantation or cardiac assist device. In patients with stable PADs who have AF, anticoagulation is the priority and suffices in most cases. In the case of recent endovascular revascularization, a period of combination therapy (anticoagulant + antiplatelet therapies) should be considered according to the bleeding and thrombotic risks. The period of combination therapy should be as brief as possible. In patients undergoing transcatheter aortic valve implantation or other structural interventions, screening for LEAD and UEAD is indicated.


ESC CardioMed ◽  
2018 ◽  
pp. 2691-2692
Author(s):  
V Aboyans

In 2011, the ESC published its first Guidelines on the Diagnosis and Management of Peripheral Arterial Diseases. This publication filled an important gap within the ESC guidelines documents compendium. Meanwhile, the ESVS released on a regular basis several guidelines documents on the management of specific localizations of arterial diseases. Both societies emphasized the need for a multidisciplinary management of these patients. When the decision was made to update these guidelines, it appeared obvious that the combination of efforts from both societies would provide the most comprehensive single document, providing updated guidelines on peripheral arterial diseases (PADs) for clinicians.


2020 ◽  
Vol 17 (6) ◽  
pp. 147916412096699
Author(s):  
Preaw Suwannasrisuk ◽  
Sarinya Sattanon ◽  
Watcharaporn Taburee ◽  
Pantitra Singkheaw ◽  
Non Sowanna ◽  
...  

In diabetes patients, urban lifestyle has been concerned as one of the risk factors for peripheral arterial disease (PAD). The aims of this study were to find out the prevalence and associated risk factors of PAD in type 2 diabetes patients who live in a non-urban community area. A total of 885 participants with type 2 diabetes mellitus were enrolled from six primary care units in the health network centered at Naresuan University Hospital, Phitsanulok, between May and June 2018. Ankle-brachial index (ABI) was performed in all subjects using a vascular screening device. PAD was defined by an ABI value of 0.9 or lesser at least on one leg. The predictors of PAD were analyzed using multiple logistic regression. The prevalence of PAD was 7.2% among 884 evaluable patients. Diabetic neuropathy and a history of macrovascular complications were significant predictors of PAD.


Sign in / Sign up

Export Citation Format

Share Document